- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01858324
Evaluation of Educational Tools for Pregnant Women
Evaluation of Educational Tools Concerning Hypertension in Ambulatory Pregnant Women, Compared With Usual Antenatal Care
Hypertensive disorders of pregnancy happen in 5% of pregnancies. Being aware of symptoms and complications may help women to present early and preserve their own and their baby's health.
The proposed research aims to evaluate the impact of educational tools in pregnant women from an ambulatory population. These tools include a detailed pamphlet (including a graphic-based summary), a magnet summarizing symptoms and appropriate action, and a video. Level of knowledge will be evaluated after one month with a validated questionnaire. We will also evaluate if getting more information about preeclampsia increases patient anxiety as well as satisfaction about the tools.
Study Overview
Detailed Description
Background: Preeclampsia is a leading cause of maternal/fetal morbidity/mortality. Pregnant women are often poorly informed on preeclampsia and seeking care too late results in maternal/fetal complications. Many healthcare providers believe that delivering information for low-risk women only make them more anxious.
Preliminary data: We published that an information pamphlet on preeclampsia increases knowledge, without increasing anxiety, and generates high satisfaction in women hospitalized for preeclampsia.
Objectives: Demonstrate that (1) ambulatory low-risk pregnant women will benefit from the pamphlet/video with improved knowledge; (2) without any increase in anxiety, and with great satisfaction.
Design: Prospective randomized controlled pilot study. Inclusion criteria: consecutive pregnant women aged ≥18 y.o. between 200-326 weeks presenting at the clinic and who read/write French or English. Exclusion criteria: Anticipated delivery or termination within one month. Intervention: pamphlet, magnet and video. Control: no educational tool. At baseline, women in both groups will answer questionnaire #1 on demographics; one month later: self-administered questionnaire #2 on knowledge, anxiety, satisfaction.
Sample size: N=178 will provide 80% power to find a significant improvement of at least 20% in knowledge score and 96% power to find a difference of at least 1 on scale for anxiety (alpha of 5%). Assuming a drop-out rate of 10%, missing answers <20%, and rate of answered questionnaire #2 of 50%, 400 subjects will be recruited.
Anticipated results: The tools will improve knowledge by about 20% in intervention group compared to control group. They will not increase anxiety over one point and will be highly appreciated by women.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Centre Hopitalier Universiatire de Sherbrooke
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women between 20+0 to 32+6 weeks pregnant
- Aged 18 years old or more
- Who present at the Blood Sampling in Pregnancy clinic
- With an adequate understanding of written and spoken French or English in order to read the pamphlet and fill out the self-administered questionnaire
Exclusion Criteria:
- Consideration of an interruption of pregnancy for maternal or fetal reasons
- Anticipated delivery within the next month.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: educational tools
Subjects will receive at time 0 the educational tools (pamphlet-including a graphic-based summary, a magnet and a 12 minutes video).
They will then have to answer a questionnaire 1 month later about knowledge, anxiety and satisfaction.
|
Subjects will receive the educational tools.
They will then receive one month after a questionnaire about knowledge, anxiety and satisfaction.
Other Names:
|
|
No Intervention: Usual antenatal care
Subjects in this group will not receive any more educational tools that what is generally offered in routine antenatal care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge about preeclampsia
Time Frame: 1 month
|
Through a questionnaire (7 questions, 35 statements, one global score)
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: 1 month
|
Question 1: 8 statements (Likert's scale 1 to 6) Question 2 more general
|
1 month
|
|
Satisfaction
Time Frame: 1 month
|
3 questions
|
1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sub-group analysis: age
Time Frame: 1 month
|
Diferences in outcomes between control and intervention groups according to group age
|
1 month
|
|
Sub-group analysis: parity
Time Frame: 1 month
|
Differences between control and intervention group according to parity.
|
1 month
|
|
Sub-group analysis: pre-pregnancy BMI
Time Frame: 1 month
|
Differences between control and intervention group according to pre-pregnancy BMI
|
1 month
|
|
Sub-group analysis: category of health care provider
Time Frame: 1 month
|
Differences between control and intervention group according to category of healthcare provider
|
1 month
|
|
Sub-group analysis: preeclampsia risk factors
Time Frame: 1 month
|
Differences between control and intervention group according to preeclampsia risk factors (pre-pregnancy diseases or a history of preeclampsia
|
1 month
|
|
Sub-group analysis: tobacco use
Time Frame: 1 month
|
Differences between control and intervention group according to tobacco use
|
1 month
|
|
Sub-group analysis:
Time Frame: 1 month
|
Differences between control and intervention group according to employment type
|
1 month
|
|
Sub-group analysis: ethnicity
Time Frame: 1 month
|
Differences between control and intervention group according to ethnicity
|
1 month
|
|
Sub-group analysis: socio-economic level
Time Frame: 1 month
|
Differences between control and intervention group according to socio-economic level
|
1 month
|
|
Sub-group analysis: educational level
Time Frame: 1 month
|
Differences between control and intervention group according to educational level
|
1 month
|
|
Sub-group analysis: marital status
Time Frame: 1 month
|
Differences between control and intervention group according to marital status
|
1 month
|
|
Sub-group analysis:video viewed on site vs. at home
Time Frame: 1 month
|
Differences between control and intervention group according to video viewed on-site vs. at home
|
1 month
|
|
Sub-group analysis:delay since last consultation of the tools
Time Frame: 1 month
|
Differences between control and intervention group according to delay since last consultation of the tools.
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nadine Sauve, MD, Centre de recherche clinique of the Centre Hopitalier Universitaire de Sherbrooke
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-025
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preeclampsia
-
Comanche BiopharmaRecruitingPreeclampsia | Preterm Preeclampsia | sFlt1 Mediated Preterm PreeclampsiaAustralia
-
MemorialCare Health SystemActive, not recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia MildUnited States
-
Christiana Care Health ServicesTerminatedPre-Eclampsia | Preeclampsia | Preterm | Preeclampsia Severe | Preeclampsia Second Trimester | Preeclampsia Complicating Childbirth | Preeclampsia PuerperiumUnited States
-
University Medical Centre LjubljanaCompletedPreeclampsia Postpartum | Preeclampsia SevereSlovenia
-
Anna Stanhewicz, PhDActive, not recruiting
-
Cedars-Sinai Medical CenterThermoFisher Scientific Brahms Biomarkers FranceCompletedGestational Hypertension | Preeclampsia Severe | Preeclampsia and Eclampsia | Chronic Hypertension in Obstetric Context | Superimposed Pre-Eclampsia | Preeclampsia MildUnited States
-
Alexander HarrisonNot yet recruitingPreeclampsia Postpartum | Preeclampsia SevereUnited States
-
Saint Thomas Hospital, PanamaRecruitingPreeclampsia | Severe PreeclampsiaPanama
-
Washington University School of MedicineCompletedPreeclampsia Postpartum | Preeclampsia SevereUnited States
Clinical Trials on Educational tools
-
Johns Hopkins UniversityCenters for Disease Control and PreventionCompletedPain, Postoperative | Opioid Use DisorderUnited States
-
Ankara UniversityUnknown
-
Hospital Israelita Albert EinsteinCompletedEvidence-Based PracticeBrazil
-
TC Erciyes UniversityCompletedArtificial Intelligence | Nursing EducationTurkey
-
University of SheffieldEthicon Endo-Surgery; HCA International Limited; DigimedCompletedFocus of Study: Cognitive Surgical Skill AcquisitionUnited Kingdom
-
West Virginia UniversityCompletedObesity | Weight Loss | Men
-
Intermountain Health Care, Inc.Active, not recruitingAntibiotic | Respiratory Infection (for Example, Pneumonia, Bronchitis) | Antibiotic Duration | Antibiotic Prescribing for Acute Respiratory-tract InfectionsUnited States
-
Aga Khan UniversityJinnah Postgraduate Medical CentreRecruitingNeurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients (PBT)Blood Cancer | Brain Tumor, PediatricPakistan
-
Brigham and Women's HospitalNot yet recruitingHospital Information Systems
-
Fondazione Don Carlo Gnocchi OnlusCampus Bio-Medico University; Istituti Clinici Scientifici Maugeri SpA; IRCCS... and other collaboratorsRecruiting